Recombinant Human ALK-7 Protein
Beta LifeScience
SKU/CAT #: BLK-00122P-100UG

Human ALK-7 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human ALK-7 Protein
Beta LifeScience
SKU/CAT #: BLK-00122P-100UG
Collections: High-quality recombinant proteins, Other recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human ALK-7 Protein is expressed from HEK293 with His tag at the C-terminus.It contains Glu21-Glu113. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q8NER5 |
Target Symbol | ALK-7 |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Glu21-Glu113 |
Mol. Weight | The protein has a predicted MW of 11.11 kDa. Due to glycosylation, the protein migrates to 20-40 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22 um filtered solution in 20mM Tris, 150mM NaCl (pH 7.5). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Arterial stiffness is an important feature of diabetic macrovascular complications. Activin receptor-like kinase 7 (ALK7), a member of type I transforming growth factor-β (TGF-β) receptors, is correlated with pathogenic risks of type 2 diabetes mellitus and cardiovascular diseases and may be involved in cardiovascular remodeling. |